For patients with breast cancer, double mastectomy does not reduce mortality
the ONA take:
According to a new study published in The Journal of the American Medical Association, despite an increase in the number of women undergoing a double mastectomy for early-stage breast cancer, the procedure does not reduce the risk of mortality compared with breast-conserving therapy with radiation.
In the study, researchers identified 189,734 women diagnosed with early-stage unilateral breast cancer between 1998 and 2011 from the California Cancer Registry. Researchers followed the patients for an average of approximately 89 months.
They found that the rate of women with early-stage breast cancer undergoing double mastectomies rose from 2% to 12.3% in 1998 and 2011, respectively. Women aged 40 and over opting for the procedure rose from 3.6% to 33% in 1998 and 2011, respectively, making this group have the highest increase. Furthermore, the rate of women undergoing unilateral mastectomies decreased during this period.
In addition, the team found that women who chose to undergo a double mastectomy did not have a lower risk of mortality compared with women who underwent breast-conserving therapy plus radiation. Women who underwent a unilateral mastectomy were found to have a higher risk of death.
The procedure does not reduce the risk of mortality.
Having a double mastectomy for early-stage breast cancer is not linked to a lower risk of death than breast-conserving therapy plus radiation, but still there is an increase in the number of women undergoing the procedure. These are the findings of a new study published in JAMA.
This is not the first study to question the benefits of a double mastectomy, or bilateral mastectomy - the removal of both breasts - for breast cancer patients. Earlier this year, Medical News Today reported on a study published in JAMA Surgery claiming the procedure is unnecessary for the majority of women.
Sign Up for Free e-newsletters
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Risk for Long-Term Cardiovascular Disease Increased for Endometrial Cancer Survivors
- Mitomycin Extravasation Protocol
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|